304 related articles for article (PubMed ID: 21867538)
1. Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
Valcárcel M; Mendoza L; Hernández JJ; Carrascal T; Salado C; Crende O; Vidal-Vanaclocha F
J Transl Med; 2011 Aug; 9():142. PubMed ID: 21867538
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium: implications for circulating cancer cell arrest in the murine liver.
Mendoza L; Carrascal T; De Luca M; Fuentes AM; Salado C; Blanco J; Vidal-Vanaclocha F
Hepatology; 2001 Aug; 34(2):298-310. PubMed ID: 11481615
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cytokine-induced microvascular arrest of tumor cells by recombinant endostatin prevents experimental hepatic melanoma metastasis.
Mendoza L; Valcárcel M; Carrascal T; Egilegor E; Salado C; Sim BK; Vidal-Vanaclocha F
Cancer Res; 2004 Jan; 64(1):304-10. PubMed ID: 14729638
[TBL] [Abstract][Full Text] [Related]
4. Mannose receptor-mediated endothelial cell activation contributes to B16 melanoma cell adhesion and metastasis in liver.
Mendoza L; Olaso E; Anasagasti MJ; Fuentes AM; Vidal-Vanaclocha F
J Cell Physiol; 1998 Mar; 174(3):322-30. PubMed ID: 9462694
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18.
Salado C; Olaso E; Gallot N; Valcarcel M; Egilegor E; Mendoza L; Vidal-Vanaclocha F
J Transl Med; 2011 May; 9():59. PubMed ID: 21569399
[TBL] [Abstract][Full Text] [Related]
6. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.
Vidal-Vanaclocha F; Fantuzzi G; Mendoza L; Fuentes AM; Anasagasti MJ; Martín J; Carrascal T; Walsh P; Reznikov LL; Kim SH; Novick D; Rubinstein M; Dinarello CA
Proc Natl Acad Sci U S A; 2000 Jan; 97(2):734-9. PubMed ID: 10639148
[TBL] [Abstract][Full Text] [Related]
7. Proangiogenic role of tumor-activated hepatic stellate cells in experimental melanoma metastasis.
Olaso E; Salado C; Egilegor E; Gutierrez V; Santisteban A; Sancho-Bru P; Friedman SL; Vidal-Vanaclocha F
Hepatology; 2003 Mar; 37(3):674-85. PubMed ID: 12601365
[TBL] [Abstract][Full Text] [Related]
8. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature.
Anasagasti MJ; Martin JJ; Mendoza L; Obrador E; Estrela JM; McCuskey RS; Vidal-Vanaclocha F
Hepatology; 1998 May; 27(5):1249-56. PubMed ID: 9581678
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.
Vidal-Vanaclocha F; Alvarez A; Asumendi A; Urcelay B; Tonino P; Dinarello CA
J Natl Cancer Inst; 1996 Feb; 88(3-4):198-205. PubMed ID: 8632494
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-18 binding protein reduces b16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium.
Carrascal MT; Mendoza L; Valcárcel M; Salado C; Egilegor E; Tellería N; Vidal-Vanaclocha F; Dinarello CA
Cancer Res; 2003 Jan; 63(2):491-7. PubMed ID: 12543807
[TBL] [Abstract][Full Text] [Related]
11. COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion.
Kuang C; Zhu Y; Guan Y; Xia J; Ouyang J; Liu G; Hao M; Liu J; Guo J; Zhang W; Feng X; Li X; Zhang J; Wu X; Xu H; Li G; Xie L; Fan S; Qiu L; Zhou W
Cell Oncol (Dordr); 2021 Jun; 44(3):643-659. PubMed ID: 33646559
[TBL] [Abstract][Full Text] [Related]
12. Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis.
Olaso E; Santisteban A; Bidaurrazaga J; Gressner AM; Rosenbaum J; Vidal-Vanaclocha F
Hepatology; 1997 Sep; 26(3):634-42. PubMed ID: 9303493
[TBL] [Abstract][Full Text] [Related]
13. IL-18 regulates melanoma VLA-4 integrin activation through a Hierarchized sequence of inflammatory factors.
Valcárcel M; Carrascal T; Crende O; Vidal-Vanaclocha F
J Invest Dermatol; 2014 Feb; 134(2):470-480. PubMed ID: 23938462
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
Majumder M; Xin X; Liu L; Girish GV; Lala PK
Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
[TBL] [Abstract][Full Text] [Related]
15. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice.
Anasagasti MJ; Alvarez A; Martin JJ; Mendoza L; Vidal-Vanaclocha F
Hepatology; 1997 Apr; 25(4):840-6. PubMed ID: 9096586
[TBL] [Abstract][Full Text] [Related]
16. Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.
Han M; Xu J; Bi Y; Jiang M; Xu X; Liu Q; Jia J
J Cancer Res Clin Oncol; 2013 Jan; 139(1):57-65. PubMed ID: 22903384
[TBL] [Abstract][Full Text] [Related]
17. Cox-2 inhibition potentiates mouse bone marrow stem cell engraftment and differentiation-mediated wound repair.
Geesala R; Dhoke NR; Das A
Cytotherapy; 2017 Jun; 19(6):756-770. PubMed ID: 28433514
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum.
Ninomiya I; Nagai N; Oyama K; Hayashi H; Tajima H; Kitagawa H; Fushida S; Fujimura T; Ohta T
Oncol Rep; 2012 Sep; 28(3):777-84. PubMed ID: 22751903
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.
Dianzani C; Brucato L; Gallicchio M; Rosa AC; Collino M; Fantozzi R
Br J Pharmacol; 2008 Mar; 153(6):1153-61. PubMed ID: 18084316
[TBL] [Abstract][Full Text] [Related]
20. [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma].
Li J; Luo SK; Hong WD; Zhou ZH; Zou WY
Ai Zheng; 2003 Apr; 22(4):346-9. PubMed ID: 12703985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
